Drug alert: Intravenous dantrolene and the risk of undissolved crystals

0

MHRA report “Some newly issued vials of intravenous dantrolene may contain crystals of undissolved dantrolene sodium following reconstitution. Draw up the reconstituted solution with a filter needle to prevent these crystals from being administered to patients. There may be a residual increased risk of injection site reactions due to crystals that may not have been removed by filtration; heightened vigilance is therefore required.”

Click here for the full drug safety update.

Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).

Main page

Share.

Comments are closed.